Praxis Precision Medicines, Inc. (PRAX)
Healthcare • Biotechnology
StockNasdaqGSUnited StatesUS74006W2070
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Praxis Precision Medicines, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 14:07. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 25 Feb 2027 08:00 | -4.05 | — | — | Upcoming |
| 09 Nov 2026 07:00 | -3.63 | -3.23 | +11.1% | Beat |
| 06 Aug 2026 08:00 | -3.69 | -2.87 | +22.2% | Beat |
| 07 May 2026 08:00 | -3.68 | -3.20 | +13.0% | Beat |
| 19 Feb 2026 07:00 | -3.13 | -3.50 | -12.0% | Miss |
| 05 Nov 2025 08:00 | -3.49 | -3.36 | +3.7% | Beat |
| 04 Aug 2025 08:00 | -3.36 | -3.31 | +1.4% | Beat |
| 02 May 2025 08:00 | -3.21 | -3.29 | -2.5% | Miss |
| 28 Feb 2025 08:00 | -2.82 | -2.94 | -4.3% | Miss |
| 06 Nov 2024 07:00 | -1.95 | -2.75 | -40.9% | Miss |
| 13 Aug 2024 07:00 | -2.32 | -1.74 | +25.0% | Beat |
| 13 May 2024 07:00 | -2.16 | -2.84 | -31.5% | Miss |
| 05 Mar 2024 07:00 | -3.17 | -2.97 | +6.2% | Beat |
| 07 Nov 2023 07:00 | -4.89 | -2.70 | +44.8% | Beat |
| 09 Aug 2023 08:00 | -10.60 | -7.35 | +30.7% | Beat |
| 11 May 2023 07:00 | -12.80 | -10.65 | +16.8% | Beat |
| 07 Feb 2023 08:00 | -12.03 | -13.05 | -8.5% | Miss |
| 09 Nov 2022 16:00 | -14.01 | -14.40 | -2.8% | Miss |
| 08 Aug 2022 16:00 | -19.27 | -19.80 | -2.7% | Miss |
| 09 May 2022 16:00 | -20.15 | -22.65 | -12.4% | Miss |
| 28 Feb 2022 06:00 | -16.05 | -19.50 | -21.5% | Miss |
| 03 Nov 2021 07:00 | -13.95 | -15.00 | -7.5% | Miss |
| 16 Aug 2021 08:00 | -10.12 | -13.20 | -30.4% | Miss |
| 11 May 2021 08:00 | -11.14 | -10.65 | +4.4% | Beat |
| 17 Mar 2021 07:00 | -5.75 | -10.50 | -82.6% | Miss |
| 23 Nov 2020 16:00 | -4.42 | -7.90 | -78.6% | Miss |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 0 | -100.0% | -303.3M | — | -13.48 | -32.0% | -249.1M |
| 2024 | 8.6M | +249.5% | -182.8M | -2,137.5% | -10.21 | +45.4% | -131.8M |
| 2023 | 2.4M | — | -123.3M | -5,037.9% | -18.69 | +73.1% | -111.2M |
| 2022 | 0 | — | -214M | — | -69.60 | — | -185.5M |
| 2021 | — | — | — | — | — | — | — |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 09 Nov 2026 – 12 Nov 2026 In progress | 285.00 | 351.64 | 279.14 | 324.76 | +16.98% | 2,987,000 | |
| 02 Nov 2026 – 06 Nov 2026 | 286.26 | 294.95 | 260.77 | 277.62 | -2.91% | 1,559,300 | |
| 26 Oct 2026 – 30 Oct 2026 | 256.36 | 290.22 | 254.30 | 285.93 | +13.03% | 1,927,600 | |
| 19 Oct 2026 – 23 Oct 2026 | 245.42 | 272.00 | 244.26 | 252.96 | +4.63% | 2,971,100 | |
| 12 Oct 2026 – 16 Oct 2026 | 257.94 | 259.50 | 236.79 | 241.76 | -6.97% | 3,056,800 | |
| 05 Oct 2026 – 09 Oct 2026 | 299.12 | 299.12 | 259.00 | 259.86 | -12.06% | 2,583,300 | |
| 28 Sep 2026 – 02 Oct 2026 | 280.78 | 298.56 | 277.90 | 295.51 | +5.25% | 2,334,600 | |
| 21 Sep 2026 – 25 Sep 2026 | 301.69 | 312.46 | 275.89 | 280.78 | -6.08% | 3,116,900 | |
| 14 Sep 2026 – 18 Sep 2026 | 337.67 | 341.70 | 295.70 | 298.95 | -10.65% | 2,508,900 | |
| 08 Sep 2026 – 11 Sep 2026 | 342.25 | 360.61 | 334.00 | 334.58 | -4.90% | 1,029,100 | |
| 252 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Guggenheim highlights top biotechnology stock (opens in a new tab) Investing.com · 12 Nov 2026 19:43
- Guggenheim Names Top Biotechnology Stock (opens in a new tab) Investing.com · 11 Nov 2026 16:11
- Praxis Precision Medicines, Inc. (PRAX) Presents at 3rd Annual Guggenheim Healthcare Innovation Conference Transcript (opens in a new tab) SeekingAlpha · 11 Nov 2026 14:59
- RBC Capital Maintains Outperform on Praxis Precision Medicine, Raises Price Target to $478 (opens in a new tab) Benzinga · 10 Nov 2026 12:17
- Wedbush Maintains Underperform on Praxis Precision Medicine, Raises Price Target to $189 (opens in a new tab) Benzinga · 10 Nov 2026 11:28
- Wells Fargo Maintains Equal-Weight on Praxis Precision Medicine, Lowers Price Target to $343 (opens in a new tab) Benzinga · 10 Nov 2026 11:10
- Praxis Precision Medicines (PRAX) Stock Looks Rich Against Its Book Value (opens in a new tab) Simply Wall St. · 10 Nov 2026 00:16
- BTIG Reiterates Buy on Praxis Precision Medicine, Maintains $826 Price Target (opens in a new tab) Benzinga · 09 Nov 2026 13:32
- Praxis Precision Medicines (NASDAQ:PRAX) Narrows Q3 Loss Ahead of Two FDA Decisions (opens in a new tab) ChartMill · 09 Nov 2026 13:30
- Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2026 Financial Results (opens in a new tab) 09 Nov 2026 12:00
- Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (opens in a new tab) 04 Nov 2026 21:01
- Is Investor Day Plans Altering The Investment Case For Praxis Precision Medicines (PRAX)? (opens in a new tab) Simply Wall St. · 28 Oct 2026 13:10
- Is Praxis Precision Medicines (PRAX) Priced Too Highly On Book Value? (opens in a new tab) Simply Wall St. · 18 Oct 2026 22:12
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 346.21 USD
- Market cap
- 9.1B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow PRAX and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.